Eliglustat, an investigational oral therapy for gaucher disease type 1: Phase 2 results after 3 years

Authors
Category Primary study
JournalHaematologica
Year 2011
This article has no abstract
Epistemonikos ID: 791e90adc3c2613b7be650033524fa0f2c839f3d
First added on: Feb 06, 2025